Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma

Min Zheng(Fujian Medical University), Kun Ping Lu(Translational Therapeutics (United States))
Oncotarget
March 7, 2017
Cited by 38


Related Papers